Premier Anti-Aging Co., Ltd. (JP:4934)
:4934
Want to see JP:4934 full AI Analyst Report?
4934 Stock Chart & Stats
¥702.00
-¥12.00(-1.43%)
At close: 4:00 PM EST
¥702.00
-¥12.00(-1.43%)
Day’s Range― - ―
52-Week Range¥576.00 - ¥979.00
Previous CloseN/A
Volume17.40K
Average Volume (3M)11.01K
Market Cap
¥5.28B
Enterprise Value¥1.37B
Total Cash (Recent Filing)¥4.66B
Total Debt (Recent Filing)¥1.11B
Price to Earnings (P/E)42.4
Beta0.97
Next Earnings
Jun 15, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)54.02
Shares Outstanding8,720,534
10 Day Avg. Volume8,960
30 Day Avg. Volume11,006
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)1.14
Price to Sales (P/S)0.47
P/FCF Ratio5.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)49.3
Revenue Forecast (FY)¥15.00B
Bulls Say, Bears Say
Bulls Say
High Gross MarginA 76.65% gross margin indicates durable product-level economics and pricing power in the company's anti‑aging portfolio. High gross margins support cash generation, absorb variable cost swings, and provide a structural buffer that helps sustain operations while management addresses top-line weakness.
Conservative LeverageA low debt-to-equity ratio (0.17) and healthy equity ratio signal a conservative capital structure, reducing refinancing and interest risks. This provides strategic flexibility for investment, R&D or M&A, and resilience through revenue cyclicality, supporting stability over the next several months.
Strong FCF ConversionNear‑one-to-one conversion of net income to free cash flow and a material improvement in FCF demonstrate the company can turn earnings into cash. Robust cash conversion enhances liquidity, funds operations or reinvestment without new debt, and supports durable financial health despite earnings volatility.
Bears Say
Declining RevenueSustained revenue decline (-7.23% last year) indicates weakening demand or market share loss in core wellness and beauty services. Persistent top‑line contraction undermines scale economies, limits reinvestment capacity, and can erode long‑term competitiveness unless new growth initiatives restore traction.
Low Net ProfitabilityA 2.91% net margin and weak operating margins show most gross profit is consumed by operating costs. This structural profitability weakness reduces retained earnings available for growth or cushioning against shocks, making long‑term returns sensitive to cost pressures and revenue volatility.
Earnings DeteriorationSharp EPS contraction (≈-57%) signals meaningful deterioration in bottom‑line performance versus prior periods. Falling earnings constrain internal funding for strategic initiatives, raise scrutiny on operational execution, and increase reliance on non‑operating measures to maintain cash flow.
Premier Anti-Aging Co., Ltd. News
4934 FAQ
What was Premier Anti-Aging Co., Ltd.’s price range in the past 12 months?
Premier Anti-Aging Co., Ltd. lowest stock price was ¥576.00 and its highest was ¥979.00 in the past 12 months.
What is Premier Anti-Aging Co., Ltd.’s market cap?
Premier Anti-Aging Co., Ltd.’s market cap is ¥5.28B.
When is Premier Anti-Aging Co., Ltd.’s upcoming earnings report date?
Premier Anti-Aging Co., Ltd.’s upcoming earnings report date is Jun 15, 2026 which is in 38 days.
How were Premier Anti-Aging Co., Ltd.’s earnings last quarter?
Premier Anti-Aging Co., Ltd. released its earnings results on Mar 12, 2026. The company reported ¥4.26 earnings per share for the quarter, beating the consensus estimate of N/A by ¥4.26.
Is Premier Anti-Aging Co., Ltd. overvalued?
According to Wall Street analysts Premier Anti-Aging Co., Ltd.’s price is currently Overvalued.
Does Premier Anti-Aging Co., Ltd. pay dividends?
Premier Anti-Aging Co., Ltd. does not currently pay dividends.
What is Premier Anti-Aging Co., Ltd.’s EPS estimate?
Premier Anti-Aging Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Premier Anti-Aging Co., Ltd. have?
Premier Anti-Aging Co., Ltd. has 8,720,534 shares outstanding.
What happened to Premier Anti-Aging Co., Ltd.’s price movement after its last earnings report?
Premier Anti-Aging Co., Ltd. reported an EPS of ¥4.26 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.688%.
Which hedge fund is a major shareholder of Premier Anti-Aging Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4934
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Premier Anti-Aging Co., Ltd.
Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. The company offers its cosmetic products under the DUO and CANADEL brands. It is also involved on the information provision and consulting services related to anti-aging, beauty, and health; research on management and beauty of beauty clinics, etc.; and marketing research and collection and analysis of various information. The company was founded in 2009 and is headquartered in Tokyo, Japan.
Technical Analysis
Ivy Cosmetics Corporation
―
HABA Laboratories, Inc.
―
C'BON COSMETICS Co., Ltd.
―
I-ne CO., LTD.
―
AXXZIA, Inc.
―